Factors associated with success of the extreme drug resistance assay in primary breast cancer specimens.
Ellis RJ, Fabian CJ, Kimler BF, Tawfik O, Mayo MS, Decelis CR, Jewell WR, Connor C, Modrell C, Praeger M, McGinness M, Mehta R, Fruehauf JP.
Ellis RJ, et al. Among authors: mayo ms.
Breast Cancer Res Treat. 2002 Jan;71(2):95-102. doi: 10.1023/a:1013843912560.
Breast Cancer Res Treat. 2002.
PMID: 11881914